The present invention relates to novel 1,3-dihydroindol-2-one (oxindole) derivatives of the formula (I)
in which
A, R3, R4, R5, R6 and R7 are defined according to claim 1, and to medicaments containing them for the treatment of diseases. In particular, the novel oxindole derivaties can be used for the control and/or prophylaxis of various vasopressin-dependent or oxytocin-dependent diseases.
本发明涉及式 (I) 的新型 1,3-二氢
吲哚-2-酮(
吲哚肟)衍
生物
其中
A、R3、R4、R5、R6 和 R7 根据权利要求 1 所定义,本发明涉及含有这些衍
生物的用于治疗疾病的药物。特别是,新型氧化
吲哚衍
生物可用于控制和/或预防各种血管
加压素依赖性或
催产素依赖性疾病。